Sees 2023 constant currency revenue growth excluding COVID-19-related revenue expected to be between 30% and 35%; and 2023 operating losses expected to be below 2022 levels.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SOPH:
- SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023
- SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023
- Sophia Genetics announces collaboration with MSK Cancer Center and AstraZeneca
- Sophia Genetics management to meet virtually with BTIG
- Laboratorio Curie expands relationship with SOPHiA GENETICS